Nicholas A.J. Botwood
Head of R&D, CMO · 2 filings · Latest: Jun 11, 2026
Syndax Pharmaceuticals Inc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SNDX | Nicholas A.J. Botwood | Head of R&D, CMO | Jun 12, 2026 | Sale | $18.14 | 31,235 | $566.6K | 60,885 | |
SNDX | Nicholas A.J. Botwood | Head of R&D, CMO | Jun 12, 2026 | Option Exercise | $13.82 | 31,235 | $431.7K | 92,120 | |
SNDX | Nicholas A.J. Botwood | Head of R&D, CMO | Jun 11, 2026 | Sale | $18.00 | 34,280 | $617.0K | 60,885 | |
SNDX | Nicholas A.J. Botwood | Head of R&D, CMO | Jun 11, 2026 | Option Exercise | $13.82 | 22,515 | $311.2K | 95,165 | |
SNDX | Botwood Nicholas A.J. | — | Jun 12, 2026 | Proposed Sale | $18.14 | 31,235 | $566.7K | — | |
SNDX | Botwood Nicholas A.J. | — | Jun 11, 2026 | Proposed Sale | $17.78 | 34,280 | $609.4K | — |